Pliant Therapeutics PLRX Insider Ownership

NASDAQ PLRX
$0.91 +0.01 (+1.52%)
At close: Oct 20, 2026 · 4:00 PM EDT

Insider Holdings by Owner

3.32Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
3.11%
■0% pp QoQ
Shares Held by Insiders
1.92Mn
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
61.92Mn
61,920,154 shares
Direct Holdings
1.48Mn
Indirect: 441.11K
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
8
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Across the past 12 months, open-market trades by Pliant Therapeutics insiders were all sales, totaling $163,620 (127.83K shares).

Form 4 Holdings

Insiders Holding PLRX

Insiders 8
Shares held 3.32Mn
Of outstanding 5.37%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Rock Ventures Iii, L.P. Third TenPercentOwner 1,839,160 0 1,839,160 55.4% 01 Dec, 2022
2 Bernard Coulie President And Ceo 505,601 0 505,601 15.2% 22 Jan, 2026
3 Keith Lamont Cummings Chief Financial Officer 297,214 0 297,214 8.9% 22 Jan, 2026
4 Hans Hull Chief Business Officer 251,708 0 251,708 7.6% 27 Jan, 2025
5 Eric Lefebvre Chief Medical Officer 240,224 0 240,224 7.2% 27 Jan, 2025
6 Mike Ouimette General Counsel Corp. Sec'Y 105,544 0 105,544 3.2% 27 Jan, 2025
7 Lily Cheung Chief Human Resource Officer 44,847 0 44,847 1.3% 22 Jan, 2026
8 Minnie Kuo Chief Operating Officer 37,806 0 37,806 1.1% 22 Jan, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

377 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
01 Oct, 2026 David Raben Chief Medical Officer Acquired A 575,000 $0.00 $0 575,000 Direct
09 Jul, 2026 Flavia Borellini Director Acquired A 60,000 $0.00 $0 60,000 Direct
09 Jul, 2026 Robert Iannone Director Acquired A 60,000 $0.00 $0 60,000 Direct
11 Jun, 2026 Hoyoung Huh Director Acquired A 70,000 $0.00 $0 70,000 Direct
11 Jun, 2026 Thomas A Mccourt Director Acquired A 70,000 $0.00 $0 70,000 Direct
11 Jun, 2026 Steve E. Krognes Director Acquired A 70,000 $0.00 $0 70,000 Direct
11 Jun, 2026 Darren S Cline Director Acquired A 70,000 $0.00 $0 70,000 Direct
11 Jun, 2026 John T Curnutte Director Acquired A 70,000 $0.00 $0 70,000 Direct
11 Jun, 2026 Gayle A Crowell Director Acquired A 70,000 $0.00 $0 70,000 Direct
17 Apr, 2026 Minnie Kuo Chief Operating Officer Disposed D 150,000 $0.00 $0 0 Direct
17 Apr, 2026 Keith Lamont Cummings Chief Financial Officer Disposed D 76,047 $0.00 $0 0 Direct
17 Apr, 2026 Bernard Coulie President And Ceo Disposed D 146,841 $0.00 $0 0 Direct
17 Apr, 2026 Lily Cheung Chief Human Resource Officer Disposed D 123,000 $0.00 $0 0 Direct
17 Apr, 2026 Bernard Coulie President And Ceo Acquired A 146,841 $0.00 $0 146,841 Direct
17 Apr, 2026 Keith Lamont Cummings Chief Financial Officer Acquired A 76,047 $0.00 $0 76,047 Direct
17 Apr, 2026 Lily Cheung Chief Human Resource Officer Acquired A 123,000 $0.00 $0 123,000 Direct
17 Apr, 2026 Minnie Kuo Chief Operating Officer Acquired A 150,000 $0.00 $0 150,000 Direct
17 Apr, 2026 Keith Lamont Cummings Chief Financial Officer Disposed D 18,198 $0.00 $0 0 Direct
17 Apr, 2026 Bernard Coulie President And Ceo Disposed D 327,262 $0.00 $0 0 Direct
17 Apr, 2026 Lily Cheung Chief Human Resource Officer Disposed D 52,000 $0.00 $0 0 Direct